MACERA LISA

@unipi.it

University of Pisa
Dept. Translational Research University of Pisa

EDUCATION

Biologist at the University of Pisa
PhD Researcher (2009-2011)
Post Doc Researcher (2011-now)

RESEARCH INTERESTS

Virology, Microbiology, Immunity, host virus relationship
44

Scopus Publications

Scopus Publications

  • Association of Torquetenovirus Viremia with Physical Frailty and Cognitive Impairment in Three Independent European Cohorts
    Robertina Giacconi, Blanca Laffon, Solange Costa, Armanda Teixeira-Gomes, Fabrizio Maggi, Lisa Macera, Pietro Giorgio Spezia, Francesco Piacenza, Alexander Bürkle, María Moreno-Villanueva, Stefano Bonassi, Vanessa Valdiglesias, Joao Paulo Teixeira, Martijn E.T. Dollé, M. Liset Rietman, Eugène Jansen, Tilman Grune, Efstathios S. Gonos, Claudio Franceschi, Miriam Capri, Birgit Weinberger, Ewa Sikora, Wolfgang Stuetz, Olivier Toussaint, Florence Debacq-Chainiaux, Antti Hervonen, Mikko Hurme, P. Eline Slagboom, Christiane Schön, Jürgen Bernhardt, Nicolle Breusing, Eduardo Pásaro, Ana Maseda, Laura Lorenzo-López, José Carlos Millán-Calenti, Mauro Provinciali, Marco Malavolta
    Gerontology, 2023
    <b><i>Introduction:</i></b> Immunosenescence and inflammaging have been implicated in the pathophysiology of frailty. Torquetenovirus (TTV), a single-stranded DNA anellovirus, the major component of the human blood virome, shows an increased replication rate with advancing age. An elevated TTV viremia has been associated with an impaired immune function and an increased risk of mortality in the older population. The objective of this study was to analyze the relation between TTV viremia, physical frailty, and cognitive impairment. <b><i>Methods:</i></b> TTV viremia was measured in 1,131 nonfrail, 45 physically frail, and 113 cognitively impaired older adults recruited in the MARK-AGE study (overall mean age 64.7 ± 5.9 years), and then the results were checked in two other independent cohorts from Spain and Portugal, including 126 frail, 252 prefrail, and 141 nonfrail individuals (overall mean age: 77.5 ± 8.3 years). <b><i>Results:</i></b> TTV viremia ≥4log was associated with physical frailty (OR: 4.69; 95% CI: 2.06–10.67, <i>p</i> < 0.0001) and cognitive impairment (OR: 3.49, 95% CI: 2.14–5.69, <i>p</i> < 0.0001) in the MARK-AGE population. The association between TTV DNA load and frailty status was confirmed in the Spanish cohort, while a slight association with cognitive impairment was observed (OR: 1.33; 95% CI: 1.000–1.773), only in the unadjusted model. No association between TTV load and frailty or cognitive impairment was found in the Portuguese sample, although a negative association between TTV viremia and MMSE score was observed in Spanish and Portuguese females. <b><i>Conclusions:</i></b> These findings demonstrate an association between TTV viremia and physical frailty, while the association with cognitive impairment was observed only in the younger population from the MARK-AGE study. Further research is necessary to clarify TTV’s clinical relevance in the onset and progression of frailty and cognitive decline in older individuals.
  • Nicotine in Combination with SARS-CoV-2 Affects Cells Viability, Inflammatory Response and Ultrastructural Integrity
    Luigi Sansone, Antonio de Iure, Mario Cristina, Manuel Belli, Laura Vitiello, Federica Marcolongo, Alfredo Rosellini, Lisa Macera, Pietro Giorgio Spezia, Carlo Tomino, Stefano Bonassi, Matteo A. Russo, Fabrizio Maggi, Patrizia Russo
    International Journal of Molecular Sciences, 2022
    The aims of our study are to: (i) investigate the ability of nicotine to modulate the expression level of inflammatory cytokines in A549 cells infected with SARS-CoV-2; (ii) elucidate the ultrastructural features caused by the combination nicotine+SARS-CoV-2; and (iii) demonstrate the mechanism of action. In this study, A549 cells pretreated with nicotine were either exposed to LPS or poly(I:C), or infected with SARS-CoV-2. Treated and untreated cells were analyzed for cytokine production, cytotoxicity, and ultrastructural modifications. Vero E6 cells were used as a positive reference. Cells pretreated with nicotine showed a decrease of IL6 and TNFα in A549 cells induced by LPS or poly(I:C). In contrast, cells exposed to SARS-CoV-2 showed a high increase of IL6, IL8, IL10 and TNFα, high cytopathic effects that were dose- and time-dependent, and profound ultrastructural modifications. These modifications were characterized by membrane ruptures and fragmentation, the swelling of cytosol and mitochondria, the release of cytoplasmic content in extracellular spaces (including osmiophilic granules), the fragmentation of endoplasmic reticulum, and chromatin disorganization. Nicotine increased SARS-CoV-2 cytopathic effects, elevating the levels of inflammatory cytokines, and inducing severe cellular damage, with features resembling pyroptosis and necroptosis. The protective role of nicotine in COVID-19 is definitively ruled out.
  • MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation
    Denise Biagini, Maria Franzini, Paolo Oliveri, Tommaso Lomonaco, Silvia Ghimenti, Andrea Bonini, Federico Vivaldi, Lisa Macera, Laurence Balas, Thierry Durand, Camille Oger, Jean-Marie Galano, Fabrizio Maggi, Alessandro Celi, Aldo Paolicchi, Fabio Di Francesco
    Free Radical Biology and Medicine, 2022
  • Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence
    Lisa Macera, Pietro Giorgio Spezia, Chiara Medici, Eleonora Rofi, Marzia Del Re, Daniele Focosi, Paola Mazzetti, David Navarro, Guido Antonelli, Romano Danesi, Mauro Pistello, Fabrizio Maggi
    Journal of Medical Virology, 2022
    Torquetenovirus (TTV) viremia is emerging as a promising tool to assess functional immune competence, to predict posttransplant immune‐related complications, and eventually to customize immunosuppression.
  • Delivery Mode Shapes the Composition of the Lower Airways Microbiota in Newborns
    Elisa Cardelli, Marco Calvigioni, Alessandra Vecchione, Lisa Macera, Diletta Mazzantini, Francesco Celandroni, Adelaide Panattoni, Mauro Pistello, Fabrizio Maggi, Emilia Ghelardi, Paolo Mannella
    Frontiers in Cellular and Infection Microbiology, 2021
    Radical alterations in the human microbiota composition are well-known to be associated with many pathological conditions. If these aberrations are established at the time of birth, the risk of developing correlated pathologies throughout life is significantly increased. For this reason, all newborns should begin their lives with a proper microbiota in each body district. The present study aimed at demonstrating a correlation between the mode of delivery and the development of a well-balanced microbiota in the lower airways of newborns. 44 pregnant women were enrolled in this study. Microbiological comparative analysis was carried out on tracheobronchial secretions of babies born through vaginal delivery (VD) or caesarean section (CS). All samples showed the presence of bacterial DNA, regardless of the mode of delivery. No viable cultivable bacteria were isolated from the CS samples. On the contrary, VD allowed colonization of the lower airways by alive cultivable bacteria. The identification of bacterial species revealed that Lactobacillus spp. and Bacteroides vulgatus were the most common microorganisms in the lower airways of vaginally-delivered newborns. Data obtained from quantitative PCRs showed a significantly higher total bacterial load, as well as Firmicutes and Lactobacillus spp. amount, in VD samples than CS ones, while no statistically significant difference was found in Torque Teno Virus (TTV) load between samples. Taken together, our findings confirm the hypothesis that passage through the maternal vaginal canal determines more beneficial colonization of the lower airways in newborns.
  • Molecular validation of pathogen-reduction technologies using rolling-circle amplification coupled with real-time PCR for torquetenovirus DNA quantification
    Daniele Focosi, Lisa Macera, Pietro Giorgio Spezia, Francesca Ceccarelli, Maria Lanza, Fabrizio Maggi
    Transfusion Medicine, 2021
    BACKGROUND Pathogen reduction technologies (PRT) based on nucleic-acid damaging chemicals and/or irradiation are increasingly being used to increase safety of blood components against emerging pathogens, such as convalescent plasma in the ongoing COVID-19 pandemic. Current methods for PRT validation are limited by the resources available to the blood component manufacturer, and quality control rely over pathogen spiking and hence invariably require sacrifice of the tested blood units: quantitative real-time PCR is the current pathogen detection method but, due to the high likelihood of detecting nonviable fragments, requires downstream pathogen culture. We propose here a new molecular validation of PRT based on the highly prevalent human symbiont torquetenovirus (TTV) and rolling circle amplification (RCA). MATERIALS AND METHODS Serial apheresis plasma donations were tested for TTV before and after inactivation with Intercept® PRT using real-time quantitative PCR (conventional validation), RCA followed by real-time PCR (our validation), and reverse PCR (for cross-validation). RESULTS While only 20% of inactivated units showed significant decrease in TTV viral load using real-time qPCR, all donations tested with RCA followed by real-time PCR showed TTV reductions. As further validation, 2 units were additionally tested with reverse PCR, which confirmed absence of entire circular genomes. DISCUSSION We have described and validated a conservative and easy-to-setup protocol for molecular validation of PRT based on RCA and real-time PCR for TTV.
  • Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer
    Daniele Focosi, Alfredo Rosellini, Pietro Giorgio Spezia, Lisa Macera, Maria Lanza, Aldo Paolicchi, Denise Biagini, Andreina Baj, Mauro Pistello, Fabrizio Maggi
    Journal of Clinical Virology Plus, 2021
    Background: Several ABO blood groups have been associated with the likelihood of infection, severity, and/or outcome of COVID-19 in hospitalized cohorts, raising the hypothesis that anti-A isoagglutinins in non-A-group recipients could act as neutralizing antibodies against SARS-CoV-2. Materials and methods: We run live virus neutralization tests using sera from 58 SARS-CoV-2 seronegative blood donors (27 O-group and 31 A-group) negatives for SARS-CoV-2 IgG to investigate what degree of neutralizing activity could be detected in their sera and eventual correlation with anti-A isoagglutinin titers. Results: We could not find clinically relevant neutralizing activity in any blood group, regardless of anti-isoagglutinin titer. Discussion: Our findings suggest that mechanisms other than neutralization explain the differences in outcomes from COVID19 seen in different ABO blood groups.
  • Nicotine upregulates ace2 expression and increases competence for sars-cov-2 in human pneumocytes
    Fabrizio Maggi, Alfredo Rosellini, Pietro Giorgio Spezia, Daniele Focosi, Lisa Macera, Michele Lai, Mauro Pistello, Antonio de Iure, Carlo Tomino, Stefano Bonassi, Patrizia Russo
    Erj Open Research, 2021
    The coronavirus disease 2019 (COVID-19) pandemic has a variable degree of severity according to underlying comorbidities and life-style. Several research groups have reported an association between cigarette smoking and increased severity of COVID-19. The exact mechanism of action is largely unclear.We exposed low angiotensin-converting enzyme 2 (ACE2)-expressing human pulmonary adenocarcinoma A549 epithelial cells to nicotine and assessed ACE2 expression at different times. We further used the nicotine-exposed cells in a virus neutralisation assay.Nicotine exposure induces rapid and long-lasting increases in gene and protein expression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor ACE2, which in turn translates into increased competence for SARS-CoV-2 replication and cytopathic effect.These findings show that nicotine worsens SARS-CoV-2 pulmonary infection and have implications for public health policies.
  • Torque teno virus microRNA detection in cerebrospinal fluids of patients with neurological pathologies
    Lorenzo Neri, Pietro Giorgio Spezia, Samuele Suraci, Lisa Macera, Stefano Scribano, Betti Giusti, Daniele Focosi, Fabrizio Maggi, Simone Giannecchini
    Journal of Clinical Virology, 2020
    BACKGROUND Torque teno virus (TTV) is a widespread anellovirus that establishes persistent infections in humans and represents the most abundant component of the human virome. TTV encodes microRNAs (miRNA) which are found both in viremic and not viremic subjects being potentially ideal tools for the virus to evade the immune system response and to maintain chronic infection in the host. OBJECTIVE To investigate TTV-DNA loads and TTV-miRNAs expression in cerebrospinal fluids (CSF) from subjects under analysis for the assessment of neurological diseases. STUDY DESIGN Detection of TTV-DNA and TTV-miRNAs (e. g. miRNA t1a, t3b, and tth8) were carried out from CSF samples of 93 subjects with neurological diseases by using universal real-time PCR, real-time RT-PCR, and next-generation sequencing (NGS) analyses. RESULTS TTV-DNA was detected in 11 of 93 (12 %) CSFs with a mean TTV load of 155 copies/mL. Conversely, 29 CSF samples (31 %) were positive for at least one TTV-miRNA, while 15 (16 %) CSFs contained all the TTV-miRNAs examined. Overall, TTV-miRNA tth8 was detected in 62 % of samples, followed by TTV miRNA t3b (56 %), and t1a (29 %). Interestingly, TTV-miRNAs were found in CSF samples that were negative for the presence of TTV-DNA. Next-generation sequencing analysis carried out from 4 TTV-DNA negative CSF samples detected reads mapped in TTV-miRNA sequences region. CONCLUSIONS These results shed novel light on the relationship between TTV and the central nervous system and make compelling furthered studies for investigating the potential role of TTV-miRNAs in neurological disorders.
  • Seroprevalence of Torque Teno Virus in hemodialysis and renal transplant patients in Australia: A cross-sectional study
    Joshua S. Davis, Ginger Chu, Prabuddhua Pathinayake, Denise Jones, Phil Giffard, Lisa Macera, Peter Choi, Nathan W. Bartlett
    Transplant Infectious Disease, 2020
    Torque teno virus (TTV) is a non‐pathogenic anellovirus commonly found in the blood of human beings. Emerging data suggest that TTV viral load is proportional to the degree of immunosuppression, but its seroprevalence is unknown in Australia. We aimed to determine the seroprevalence of TTV in an Australian population of renal patients.
  • Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors
    D. Focosi, P.G. Spezia, L. Macera, S. Salvadori, D. Navarro, M. Lanza, G. Antonelli, M. Pistello, F. Maggi
    Clinical Microbiology and Infection, 2020
  • Redondovirus DNA in human respiratory samples
    Pietro Giorgio Spezia, Lisa Macera, Paola Mazzetti, Michele Curcio, Chiara Biagini, Ilaria Sciandra, Ombretta Turriziani, Michele Lai, Guido Antonelli, Mauro Pistello, Fabrizio Maggi
    Journal of Clinical Virology, 2020
  • Prevalence and loads of torquetenovirus in the European mark-age study population
    Robertina Giacconi, Fabrizio Maggi, Lisa Macera, Pietro Giorgio Spezia, Mauro Pistello, Mauro Provinciali, Francesco Piacenza, Andrea Basso, Alexander Bürkle, María Moreno-Villanueva, Martijn E T Dollé, Eugène Jansen, Tilman Grune, Wolfgang Stuetz, Efstathios S Gonos, Christiane Schön, Jürgen Bernhardt, Beatrix Grubeck-Loebenstein, Ewa Sikora, Magdalena Dudkowska, Dorota Janiszewska, Olivier Toussaint, Florence Debacq-Chainiaux, Claudio Franceschi, Miriam Capri, Antti Hervonen, Mikko Hurme, Eline Slagboom, Nicolle Breusing, Eugenio Mocchegiani, Marco Malavolta
    Journals of Gerontology Series A Biological Sciences and Medical Sciences, 2020
  • Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2
    Sara Galimberti, Mario Petrini, Claudia Baratè, Federica Ricci, Serena Balducci, Susanna Grassi, Francesca Guerrini, Elena Ciabatti, Sandra Mechelli, Antonello Di Paolo, Chiara Baldini, Laura Baglietto, Lisa Macera, Pietro Giorgio Spezia, Fabrizio Maggi
    Frontiers in Oncology, 2020
  • DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model
    Paola Quaranta, Giulia Lottini, Giulia Chesi, Flavia Contrafatto, Roberta Russotto, Lisa Macera, Michele Lai, Pietro Giorgio Spezia, Annalaura Brai, Maurizio Botta, Giulia Freer, Mauro Pistello
    Antiviral Research, 2020
  • Lack of Marseillevirus DNA in immunocompetent and immunocompromised Italian patients
    Lisa Macera, Pietro Giorgio Spezia, Daniele Focosi, Paola Mazzetti, Guido Antonelli, Mauro Pistello, Fabrizio Maggi
    Journal of Medical Virology, 2020
  • Microbiome in chronic obstructive pulmonary disease: Role of natural products against microbial pathogens
    Alessia Santoro, Carlo Tomino, Giulia Prinzi, Vittorio Cardaci, Massimo Fini, Lisa Macera, Patrizia Russo, Fabrizio Maggi
    Current Medicinal Chemistry, 2020
  • Kinetics of Alphatorquevirus plasma DNAemia at late times after allogeneic hematopoietic stem cell transplantation
    Eliseo Albert, Carlos Solano, Estela Giménez, Daniele Focosi, Ariadna Pérez, Lisa Macera, José Luis Piñana, Eva María Mateo, Juan Carlos Hernández Boluda, Fabrizio Maggi, David Navarro
    Medical Microbiology and Immunology, 2019
  • Low prevalence of Gemycircularvirus DNA in immunocompetent and immunocompromised subjects
    New Microbiologica, 2019
  • Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients
    Fabrizio Maggi, Daniele Focosi, Maura Statzu, Gabriele Bianco, Cristina Costa, Lisa Macera, Pietro Giorgio Spezia, Chiara Medici, Eliseo Albert, David Navarro, Carolina Scagnolari, Mauro Pistello, Rossana Cavallo, Guido Antonelli
    Scientific Reports, 2018
  • Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects
    Robertina Giacconi, Fabrizio Maggi, Lisa Macera, Mauro Pistello, Mauro Provinciali, Simone Giannecchini, Francesco Martelli, Pietro Giorgio Spezia, Erminia Mariani, Roberta Galeazzi, Laura Costarelli, Lorenzo Iovino, Sara Galimberti, Lorenzo Nisi, Francesco Piacenza, Marco Malavolta
    Experimental Gerontology, 2018
  • Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples
    Francesco Martelli, Lisa Macera, Pietro Giorgio Spezia, Chiara Medici, Mauro Pistello, Daniele Guasti, Paolo Romagnoli, Fabrizio Maggi, Simone Giannecchini
    Virology Journal, 2018
  • Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation
    Eliseo Albert, Ignacio Torres, Alberto Talaya, Estela Giménez, José Luis Piñana, Juan Carlos Hernández-Boluda, Daniele Focosi, Lisa Macera, Fabrizio Maggi, Carlos Solano, David Navarro
    Journal of Medical Virology, 2018
  • High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation
    Lorenzo Iovino, Francesco Mazziotta, Giovanni Carulli, Francesca Guerrini, Riccardo Morganti, Valentina Mazzotti, Fabrizio Maggi, Lisa Macera, Enrico Orciuolo, Gabriele Buda, Edoardo Benedetti, Francesco Caracciolo, Sara Galimberti, Mauro Pistello, Mario Petrini
    Leukemia Research, 2018
  • The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
    E Albert, C Solano, E Giménez, D Focosi, A Pérez, L Macera, J L Piñana, J C H Boluda, F Maggi, D Navarro
    Bone Marrow Transplantation, 2018
  • Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients
    Eliseo Albert, Carlos Solano, Tania Pascual, Ignacio Torres, Lisa Macera, Daniele Focosi, Fabrizio Maggi, Estela Giménez, Paula Amat, David Navarro
    Journal of Clinical Virology, 2017
  • Cyclovirus Vietnam DNA in immunodeficient patients
    Lisa Macera, Daniele Focosi, Maria Linda Vatteroni, Aldo Manzin, Guido Antonelli, Mauro Pistello, Fabrizio Maggi
    Journal of Clinical Virology, 2016
  • Investigation on torquetenovirus (TTV) microRNA transcriptome in vivo
    Tiziano Vignolini, Lisa Macera, Guido Antonelli, Mauro Pistello, Fabrizio Maggi, Simone Giannecchini
    Virus Research, 2016
  • Lack of KIs virus DNA in plasma and cerebrospinal fluid in Italy
    New Microbiologica, 2015
  • Global impact of torque teno virus infection in wild and domesticated animals
    Aldo Manzin, Francesca Mallus, Lisa Macera, Fabrizio Maggi, Sylvain Blois
    Journal of Infection in Developing Countries, 2015
  • Lack of usutu virus RNA in cerebrospinal fluid of patients with encephalitis of unknown etiology, Tuscany, Italy
    Fabrizio Maggi, Paola Mazzetti, Daniele Focosi, Lisa Macera, Carolina Scagnolari, Aldo Manzin, Guido Antonelli, Luca Ceccherini Nelli
    Journal of Medical Virology, 2015
  • Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells
    Daniele Focosi, Lisa Macera, Ugo Boggi, Luca Ceccherini Nelli, Fabrizio Maggi
    Journal of General Virology, 2015
  • No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan
    D. Focosi, L. Macera, E. Ciabatti, S. Galimberti, M. Petrini, et al.
    Infection, 2014
  • Torque teno virus viremia correlates with intensity of maintenance immunosuppression in adult orthotopic liver transplant
    Daniele Focosi, Lisa Macera, Mauro Pistello, Fabrizio Maggi
    Journal of Infectious Diseases, 2014
  • High prevalence of co-infection with multiple torque teno sus virus species in italian pig herds
    Sylvain Blois, Francesca Mallus, Manuele Liciardi, Cristian Pilo, Tania Camboni, et al.
    Plos One, 2014
  • Human gyrovirus is not found in human CD34+ hematopoietic stem cells from peripheral blood or umbilical cord
    Lisa Macera, Daniele Focosi, Rossella Giannelli, Maria Bulleri, Alessandra Zucca, et al.
    Journal of Clinical Virology, 2013
  • Human gyrovirus DNA in human blood, Italy
    Fabrizio Maggi, Lisa Macera, Daniele Focosi, Maria Linda Vatteroni, Ugo Boggi, et al.
    Emerging Infectious Diseases, 2012
  • Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab
    Simone Giannecchini, Valeria Clausi, Alessandra Vultaggio, Lisa Macera, Fabrizio Maggi, et al.
    Journal of Neurovirology, 2012
  • Absence of xenotropic murine leukemia virus-related virus in Italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis
    F. Maggi, L. Bazzichi, F. Sernissi, P. Mazzetti, L. Lanini, et al.
    International Journal of Immunopathology and Pharmacology, 2012
  • Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients
    F. Maggi, D. Focosi, L. Lanini, S. Sbranti, P. Mazzetti, et al.
    Clinical Microbiology and Infection, 2012
  • A novel rolling circle amplification assay to detect members of the family Anelloviridae in pigs and humans
    Lisa Macera, Martí Cortey, Fabrizio Maggi, Joaquim Segalés, Tuija Kekarainen
    Virus Research, 2011
  • Genetic variability and phylogeny of Torque teno sus virus 1 (TTSuV1) and 2 (TTSuV2) based on complete genomes
    Martí Cortey, Lisa Macera, Joaquim Segalés, Tuija Kekarainen
    Veterinary Microbiology, 2011
  • Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution
    Daniele Focosi, Fabrizio Maggi, Melania Albani, Lisa Macera, Valentina Ricci, et al.
    Journal of Clinical Virology, 2010
  • Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9
    Jara Rocchi, Valentina Ricci, Melania Albani, Letizia Lanini, Elisabetta Andreoli, et al.
    Virology, 2009